Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Quinlivan ML, Jensen NJ, Radford KW, Schmid DS.

J Clin Microbiol. 2012 May;50(5):1533-8. doi: 10.1128/JCM.06630-11. Epub 2012 Feb 29.

3.

Clinical and molecular aspects of the live attenuated Oka varicella vaccine.

Quinlivan M, Breuer J.

Rev Med Virol. 2014 Jul;24(4):254-73. doi: 10.1002/rmv.1789. Epub 2014 Mar 29. Review.

PMID:
24687808
4.

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.

Quinlivan M, Gershon AA, Steinberg SP, Breuer J.

J Med Virol. 2005 Jan;75(1):174-80.

PMID:
15543576
5.

DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.

Gomi Y, Ozaki T, Nishimura N, Narita A, Suzuki M, Ahn J, Watanabe N, Koyama N, Ushida H, Yasuda N, Nakane K, Funahashi K, Fuke I, Takamizawa A, Ishikawa T, Yamanishi K, Takahashi M.

Vaccine. 2008 Oct 16;26(44):5627-32. doi: 10.1016/j.vaccine.2008.07.069. Epub 2008 Aug 14.

PMID:
18706951
6.

Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification.

Higashimoto Y, Ihira M, Ohta A, Inoue S, Usui C, Asano Y, Yoshikawa T.

J Clin Microbiol. 2008 Aug;46(8):2665-70. doi: 10.1128/JCM.00216-08. Epub 2008 Jun 11.

7.

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.

Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM.

Virology. 2005 Feb 5;332(1):337-46.

8.

Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.

Levin MJ, DeBiasi RL, Bostik V, Schmid DS.

J Infect Dis. 2008 Nov 15;198(10):1444-7. doi: 10.1086/592452.

PMID:
18826373
9.

DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.

Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS.

J Infect Dis. 2007 Feb 15;195(4):502-10. Epub 2007 Jan 10.

PMID:
17230409
10.
11.

Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.

Sauerbrei A, Bohn K, Zell R, Wutzler P.

J Clin Microbiol. 2009 Nov;47(11):3717-20. doi: 10.1128/JCM.01550-09. Epub 2009 Aug 26.

12.

Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains.

Koshizuka T, Ota M, Yamanishi K, Mori Y.

Virology. 2010 Sep 30;405(2):280-8. doi: 10.1016/j.virol.2010.06.016. Epub 2010 Jul 3.

13.

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Quinlivan ML, Gershon AA, Steinberg SP, Breuer J.

J Infect Dis. 2004 Aug 15;190(4):793-6. Epub 2004 Jul 15.

PMID:
15272408
14.

The safety profile of varicella vaccine: a 10-year review.

Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125. Review.

PMID:
18419392
15.

Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.

Uebe B, Sauerbrei A, Burdach S, Horneff G.

Eur J Pediatr. 2002 Aug;161(8):442-4. Epub 2002 Jun 25.

PMID:
12172829
16.

The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.

Peters GA, Tyler SD, Carpenter JE, Jackson W, Mori Y, Arvin AM, Grose C.

J Virol. 2012 Oct;86(19):10695-703. doi: 10.1128/JVI.01067-12. Epub 2012 Jul 25.

17.

Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.

Sauerbrei A, Rubtcova E, Wutzler P, Schmid DS, Loparev VN.

J Clin Microbiol. 2004 Dec;42(12):5604-8.

18.

Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains.

Ihira M, Higashimoto Y, Kawamura Y, Sugata K, Ohashi M, Asano Y, Yoshikawa T.

J Virol Methods. 2013 Nov;193(2):308-13. doi: 10.1016/j.jviromet.2013.06.031. Epub 2013 Jun 29.

PMID:
23820238
19.

Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.

Ota K, Kim V, Lavi S, Ford-Jones EL, Tipples G, Scolnik D, Tellier R.

Pediatr Infect Dis J. 2008 Sep;27(9):847-8. doi: 10.1097/INF.0b013e318170af75.

PMID:
18664930
20.

Molecular analysis of the Oka vaccine strain of varicella-zoster virus.

Yamanishi K.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S45-8. doi: 10.1086/522122. Review.

PMID:
18419407

Supplemental Content

Support Center